{"entity":{"type":"insider","cik":"0001805556","url":"/insider/0001805556","json_url":"/insider/0001805556.json","name":"Hansard Adam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2021-05-28","last":"2024-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Hansard Adam","source":"filing","n_filings":5,"first_seen":"2021-05-28","last_seen":"2024-03-18"}],"transactions":[{"id":2183899,"accession":"0001096906-24-000493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001096906-24-000493","line_url":"/filing/0001096906-24-000493#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics, Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001805556","owner_name":"Hansard Adam","owner_display_name":"Hansard Adam","owner_url":"/insider/0001805556","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48871.0,"shares_display":"48,871","price_per_share":5.39,"price_display":"5.39","price_state":"stated","total_value":263414.69,"total_display":"263,414.69","total_whole":"263,415","shares_owned_after":732919.0,"shares_owned_after_display":"732,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider"},{"id":8548025,"accession":"0001209191-23-057115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057115","line_url":"/filing/0001209191-23-057115#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001805556","owner_name":"Hansard Adam","owner_display_name":"Hansard Adam","owner_url":"/insider/0001805556","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":965.0,"shares_display":"965","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":1901.05,"total_display":"1,901.05","total_whole":"1,901","shares_owned_after":381790.0,"shares_owned_after_display":"381,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":8078994,"accession":"0001209191-23-050890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050890","line_url":"/filing/0001209191-23-050890#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001805556","owner_name":"Hansard Adam","owner_display_name":"Hansard Adam","owner_url":"/insider/0001805556","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9720.0,"shares_display":"9,720","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":26244.0,"total_display":"26,244.00","total_whole":"26,244","shares_owned_after":382755.0,"shares_owned_after_display":"382,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8287277,"accession":"0001209191-23-003288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003288","line_url":"/filing/0001209191-23-003288#line-2","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001805556","owner_name":"Hansard Adam","owner_display_name":"Hansard Adam","owner_url":"/insider/0001805556","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4495.0,"shares_display":"4,495","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":4090.45,"total_display":"4,090.45","total_whole":"4,090","shares_owned_after":92475.0,"shares_owned_after_display":"92,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider"},{"id":4273934,"accession":"0001209191-21-036685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036685","line_url":"/filing/0001209191-21-036685#line-1","is_derivative":false,"issuer_cik":"0001697532","issuer_name":"Applied Therapeutics Inc.","issuer_ticker":"APLT","issuer_name_source":null,"issuer_url":"/issuer/0001697532","owner_cik":"0001805556","owner_name":"Hansard Adam","owner_display_name":"Hansard Adam","owner_url":"/insider/0001805556","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2894.0,"shares_display":"2,894","price_per_share":18.35,"price_display":"18.35","price_state":"stated","total_value":53104.9,"total_display":"53,104.90","total_whole":"53,105","shares_owned_after":33570.0,"shares_owned_after_display":"33,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001697532","name":"Applied Therapeutics, Inc.","url":"/issuer/0001697532","role":"Officer (Chief Commercial Officer)","n_filings":5,"first_seen":"2021-05-28","last_seen":"2024-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001805556","retrieved_at":"2026-08-25T11:38:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}